Hypothetical case - For market research purposes only

The DREAMM-7 Clinical Trial

Learn about DREAMM-7, an ongoing trial evaluating the efficacy and safety of the combination of belantamab mafodotin-blmf and Vd (BVd) compared with the combination of daratumumab and Vd (D-Vd) in patients with RRMM.

${articleImageText}